This information is intended for US healthcare professionals. If you are a healthcare professional, click “I Agree” to continue.

Symptom relief for NOMID, a Severe Autoinflammatory Disease

Kineret is the first and only therapy approved by the FDA to treat newborns, children, and adults with Neonatal-Onset Multisystem Inflammatory Disease (NOMID).

  • Kineret is a type of medication known as a selective interleukin-1 (IL-1) blocker. It reduces symptoms by lowering the levels of IL-1, a substance that triggers inflammation in the body
  • In studies, patients taking Kineret reported significant improvement in symptoms in the first three months. The time for improvement varies from patient to patient

What causes NOMID?

Autoinflammatory diseases are
usually genetic. Does NOMID
run in families?

Find out here


Kineret® is a prescription medicine called an interleukin-1 receptor antagonist (IL-1ra) used to:

Kineret is not for children with Juvenile Rheumatoid Arthritis


Do not take Kineret if you are allergic to:

Before you use Kineret, tell your healthcare provider if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.Kineret and other medicines may affect each other and cause serious side effects. Especially tell your healthcare provider if you take certain other medicines that affect your immune system called Tumor Necrosis Factor (TNF) Blockers. Ask your healthcare provider for a list of these medicines if you are not sure.

Kineret may cause serious side effects, including:

The most common side effects of Kineret for RA include: 


The most common side effects of Kineret for NOMID include:

Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all of the possible side effects of Kineret. For more information ask your healthcare provider or pharmacist.

Please see full Prescribing Information